Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

Clinical trial NCT01743651 · COMPLETED

Trial details

NCT number: NCT01743651
Sponsor: RVL Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Spasticity Multiple Sclerosis

Start date: 2012-11-01
Primary completion: 2014-04-01
Enrollment: 353

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.